Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015-Reference-Cited by-同舟云学术

Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015

Published:2016-03-18 Issue:10 Volume:65 Page:257-262
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Petersen Brett W.,Harms Tiara J.,Reynolds Mary G.,Harrison Lee H.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference21 articles.

1. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001.;Rotz;MMWR Recomm Rep,2001

2. Newly licensed smallpox vaccine to replace old smallpox vaccine.;CDC;MMWR Morb Mortal Wkly Rep,2008

3. Fenner F, Henderson D, Arita I, Jezek Z, Ladnyi I. Smallpox and its eradication. Geneva, Switzerland: World Health Organization; 1988.

4. ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.;Greenberg;Expert Opin Investig Drugs,2008

5. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.;Frey;Vaccine,2009

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cross-sectional investigation of factors influencing mpox vaccine hesitancy for students in Southwest China;Human Vaccines & Immunotherapeutics;2024-02

2. Plausible reasons for the resurgence of Mpox (formerly Monkeypox): an overview;Tropical Diseases, Travel Medicine and Vaccines;2023-12-25

3. Environmental detection and spreading of mpox in healthcare settings: a narrative review;Frontiers in Microbiology;2023-12-21

4. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8;PLOS Neglected Tropical Diseases;2023-12-15

5. Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults;Clinical Infectious Diseases;2023-11-15